Eclat Pharma And Aerosols Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 17-06-2024
- Paid Up Capital ₹ 0.62 M
as on 17-06-2024
- Company Age 33 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 24.30 M
as on 17-06-2024
- Satisfied Charges ₹ 19.22 M
as on 17-06-2024
- Revenue 30.10%
(FY 2023)
- Profit 926.08%
(FY 2023)
- Ebitda -11.09%
(FY 2023)
- Net Worth 12.57%
(FY 2023)
- Total Assets 19.52%
(FY 2023)
About Eclat Pharma And Aerosols
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.62 M.
The company currently has active open charges totaling ₹2.43 Cr. The company has closed loans amounting to ₹1.92 Cr, as per Ministry of Corporate Affairs (MCA) records.
Urvashi Pradhan, Dhruva Pradhan, Abhishek Pradhan, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239MH1991PTC062241
- Company No.
062241
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jun 1991
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Eclat Pharma And Aerosols Pvt Ltd offer?
Eclat Pharma And Aerosols Pvt Ltd offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Antiseptic Liquid & Cream, Pain Relief Drugs & Pharmaceuticals, Pain Killers, Perfume and Fragrances, Body Spray, Hand Sanitizer & Disinfectant, Cleaning Liquids & Wipes, Disinfectant Spray, Mobile Phone & Accessories.
Who are the key members and board of directors at Eclat Pharma And Aerosols?
Board Members(4)
Financial Performance and Corporate Structure Insights of Eclat Pharma And Aerosols.
Eclat Pharma And Aerosols Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 30.1% increase. The company also saw a substantial improvement in profitability, with a 926.08% increase in profit. The company's net worth Soared by an impressive increase of 12.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eclat Pharma And Aerosols?
In 2023, Eclat Pharma And Aerosols had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ultra Aero Products Private Limited
Active
27 years 8 months Urvashi Pradhan, Dhruva Pradhan and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Mar 2013 | ₹2.43 Cr | Open |
Others Creation Date: 23 Mar 2019 | ₹0.52 M | Satisfied |
Vasai Janata Sahkari Bank Ltd Creation Date: 04 Jul 2014 | ₹0.80 M | Satisfied |
How Many Employees Work at Eclat Pharma And Aerosols?
Eclat Pharma And Aerosols has a workforce of 34 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eclat Pharma And Aerosols, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eclat Pharma And Aerosols's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
